An official American Thoracic Society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 9, 2012, Pages 1004-1014

  Meyer, Keith C ^a   Raghu, Ganesh ^a   Baughman, Robert P ^a   Brown, Kevin K ^a   Costabel, Ulrich ^a   Du Bois, Roland M ^a   Drent, Marjolein ^a   Haslam, Patricia L ^a   Kim, Dong Soon ^a   Nagai, Sonoko ^a   Rottoli, Paola ^a   Saltini, Cesare ^a   Selman, Moisés ^a   Strange, Charlie ^a   Wood, Brent ^a  

^a NONE

Author keywords

Bronchoalveolar lavage; Bronchoscopy; Cell differential count; Interstitial lung disease; Lung diseases

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC PNEUMONITIS; ASTHMA; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHITIS; CD4 CD8 RATIO; CELL STRUCTURE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; EOSINOPHIL; EVIDENCE BASED MEDICINE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOCOMPETENT CELL; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHOCYTOSIS; MACROPHAGE; MEDICAL HISTORY; MEDICAL LITERATURE; MEDICAL SOCIETY; MEDLINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION PNEUMONIA; REVIEW; SCLERODERMA; SMOKING; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY;

ADULT; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HUMANS; LUNG DISEASES, INTERSTITIAL; SPECIMEN HANDLING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84860621394     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201202-0320ST     Document Type: Review

References (61)

1. King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med 2005;172:268-279.
2. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
3. Noth I, Martinez FJ. Recent advances in idiopathic pulmonary fibrosis. Chest 2007;132:637-650. (Pubitemid 47282399)
4. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
5. Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, Gross BH, Jain A, Strawderman RL, Flint A, Lynch JP, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001;164:1722-1727. (Pubitemid 33124165)
6. Papanikolaou IC, Drakopanagiotakis F, Polychronopoulos VS. Acute exacerbations of interstitial lung diseases. Curr Opin Pulm Med 2010; 16:480-486.
7. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007;176: 636-643. (Pubitemid 47503070)
8. Klech H, Pohl W, editors. Technical recommendations and guidelines for bronchoalveolar lavage (BAL): report of the European society of pneumology task group. Eur Respir J 1989;2:561-585. (Pubitemid 19170588)
9. Klech H, Hutter C, editors. Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European society of pneumonolgy task group on BAL. Eur Respir J 1990;3:937-976.
10. Klech H, Hutter C, Costabel U, editors. Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European society of pneumology task group on BAL. Eur Respir Rev 1992;2:47-127.
11. Haslam PL, Baughman RP. Report of ERS task force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999;14:245-248. (Pubitemid 29461283)
12. The BAL Co-operative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990;141:S169-S202.
13. Müller NL, Fraser RS, Lee KS, Johkoh T. Diseases of the lung. Philadelphia: Lippincott, Williams & Wilkins; 2003.
14. Collins J. CT signs and patterns of lung disease. Radiol Clin North Am 2001;39:1115-1135. (Pubitemid 33021449)
15. Kanne JP. Interstitial lung disease (ILD): imaging finding, and the role of imaging in the evaluating the patient with known or suspected ILD. Semin Roentgenol 2010;45:3.
16. Wells AU. The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease. Eur Respir Rev 2010;19:237-241.
17. Steinberg KP, Mitchell DR, Maunder RJ, Milberg JA, Whitcomb ME, Hudson LD. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1993;148: 556-561. (Pubitemid 23263760)
18. Hertz MI, Woodward ME, Gross CR, Swart M, Marcy TW, Bitterman PB. Safety of bronchoalveolar lavage in the critically ill, mechanically ventilated patient. Crit Care Med 1991;19:1526-1532.
19. Hiwatari N, Shimura S, Takishima T, Shirato K. Bronchoalveolar lavage as a possible cause of acute exacerbation in idiopathic pulmonary fibrosis patients. Tohoku J Exp Med 1994;174:379-386.
20. Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006;27:143-150. (Pubitemid 43092678)
21. Dransfield MT, Garver RI, Weill D. Standardized guidelines for surveillance bronchoscopy reduce complications in lung transplant recipients. J Heart Lung Transplant 2004;23:110-114. (Pubitemid 38084836)
22. Ahmad M, Livingston DR, Golish JA, Mehta AC, Wiedemann HP. The safety of outpatient transbronchial biopsy. Chest 1986;90:403-405. (Pubitemid 16014378)
23. Simpson FG, Arnold AG, Purvis A, Belfield PW, Muers MF, Cooke NJ. Postal survey of bronchoscopic practice by physicians in the UK. Thorax 1986;41:311-317. (Pubitemid 16102091)
24. Kramer MR, Berkman N, Mintz B, Godfrey S, Saute M, Amir G. The role of open lung biopsy in the management and outcome of patients with diffuse lung disease. Ann Thorac Surg 1998;65:198-202. (Pubitemid 28105892)
25. Utz JP, Ryu JH, Douglas WW, Hartman TE, Tazelaar HD, Myers JL, Allen MS, Schroeder DR. High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J 2001;17: 175-179. (Pubitemid 32600574)
26. Garcia JG, Wolven RG, Garcia PL, Keogh BA. Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases. Am Rev Respir Dis 1986;133:444-449. (Pubitemid 16126279)
27. Sterclova M, Vasakova M, Dutka J, Kalanin J. Extrinsic allergic alveolitis: comparative study of the bronchoalveolar lavage profiles and radiological presentation. Postgrad Med J 2006;82:598-601. (Pubitemid 44476218)
28. Clements PJ, Goldin JG, Kleerup EC, Furst DE, Elashoff RM, Tashkin DP, Roth MD. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis. Arthritis Rheum 2004;50:1909-1917. (Pubitemid 38728980)
29. Agusti C, Xaubet A, Luburich P, Ayuso MC, Roca J, Rodriguez-Roisin R. Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis. Thorax 1996;51:841-845. (Pubitemid 26274088)
30. Ziora D, Grzanka P, Mazur B, Niepsuj G, Oklek K. BAL from two different lung segments indicated by high resolution computed tomography (HRCT) in patients with sarcoidosis. I. Evaluation of alveolitis homogeneity and estimation of HRCT usefulness in selection of lung region for BAL [in Polish]. Pneumonol Alergol Pol 1999; 67:422-434.
31. Rámila E, Sureda A, Martino R, Santamaría A, Franquet T, Puzo C, Montesinos J, Perea G, Sierra J. Bronchoscopy guided by highresolution computed tomography for the diagnosis of pulmonary infections in patients with hematologic malignancies and normal plain chest X-ray. Haematologica 2000;85:961-966.
32. Allen JN, Davis WB, Pacht ER. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis 1990; 142:642-647. (Pubitemid 20292729)
33. Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN. Acute eosinophilic pneumonia: a summary of 15 cases and review of the literature. Medicine (Baltimore) 1996;75:334-342. (Pubitemid 27009235)
34. Sitbon O, Bidel N, Dussopt C, Azarian R, Braud ML, Lebargy F, Fourme T, de Blay F, Piard F, Camus P. Minocycline pneumonitis and eosinophilia: a report on eight patients. Arch Intern Med 1994;154: 1633-1640.
35. Costabel U, Uzaslan E, Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med 2004;25:25-35. (Pubitemid 38296328)
36. Poulter LW, Rossi GA, Bjermer L, Costabel U, Israel-Biet D, Klech H, Pohl W, Velluti G. The value of bronchoalveolar lavage in the diagnosis and prognosis of sarcoidosis. Eur Respir J 1990;3:943-944.
37. Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993;104:352-361. (Pubitemid 23229497)
38. Keogh BA, Hunninghake GW, Line BR, Crystal RG. The alveolitis of pulmonary sarcoidosis: evaluation of natural history and alveolitis-dependent changes in lung function. Am Rev Respir Dis 1983;128: 256-265. (Pubitemid 13037034)
39. Laviolette M, La Forge J, Tennina S, Boulet LP. Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis. Chest 1991;100:380-384.
40. Ratjen F, Costabel U, Griese M, Paul K. Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis. Eur Respir J 2003;21:144-148. (Pubitemid 36150314)
41. Yoshizawa Y, Ohtani Y, Hayakawa H, Sato A, Suga M, Ando M. Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey. J Allergy Clin Immunol 1999;103:315-320. (Pubitemid 29095838)
42. Pardo A, Smith KM, Abrams J, Coffman R, Bustos M, McClanahan TK, Grein J, Murphy EE, Zlotnik A, Selman M. CCL18/DC-CK-1/PARC up-regulation in hypersensitivity pneumonitis. J Leukoc Biol 2001;70: 610-616. (Pubitemid 32954772)
43. Schnabel A, Richter C, Bauerfeind S, GrossWL. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis. Thorax 1997;52:377-379. (Pubitemid 27204903)
44. Akoun GM, Cadranel JL, Rosenow EC III, Milleron BJ. Bronchoalveolar lavage cell data in drug-induced pneumonitis. Allerg Immunol (Paris) 1991;23:245-252.
45. Shimizu S, Yoshinouchi T, Ohtsuki Y, Fujita J, Sugiura Y, Banno S, Yamadori I, Eimoto T, Ueda R. The appearance of s-100 proteinpositive dendritic cells and the distribution of lymphocyte subsets in idiopathic nonspecific interstitial pneumonia. Respir Med 2002;96:770-776. (Pubitemid 35238100)
46. Ryu YJ, Chung MP, Han J, Kim TS, Lee KS, Chun EM, Kyung SY, Jeong SH, Colby TV, Kim H, et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir Med 2007;101:655-660. (Pubitemid 46196313)
47. Meyer K. Bronchoalveolar lavage in the diagnosis and management of interstitial lung disease. Clin Pulm Med 2007;141:148-156. (Pubitemid 46763350)
48. Sutinen S, Riska H, Backman R, Sutinen SH, Froseth B. Alveolar lavage fluid (ALF) of normal volunteer subjects: cytologic, immunocytochemical, and biochemical reference values. Respir Med 1995;89:85-92.
49. Drent M,Wagenaar S, van Velzen-Blad H, Mulder PG, Hoogsteden HC, van den Bosch JM. Relationship between plasma cell levels and profile of bronchoalveolar lavage fluid in patients with subacute extrinsic allergic alveolitis. Thorax 1993;48:835-839. (Pubitemid 23244348)
50. Ettensohn DB, Jankowski MJ, Duncan PG, Lalor PA. Bronchoalveolar lavage in the normal volunteer subject: I. Technical aspects and intersubject variability. Chest 1988;94:275-280.
51. Barbers RG, Gong H Jr, Tashkin DP, Oishi J, Wallace JM. Differential examination of bronchoalveolar lavage cells in tobacco cigarette and marijuana smokers. Am Rev Respir Dis 1987;135:1271-1275. (Pubitemid 18021520)
52. Merchant RK, Schwartz DA, Helmers RA, Dayton CS, Hunninghake GW. Bronchoalveolar lavage cellularity: the distribution in normal volunteers. Am Rev Respir Dis 1992;146:448-453.
53. Welker L, Jorres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004;24:1000-1006. (Pubitemid 39642292)
54. Drent M, van Velzen-Blad H, Diamant M, Hoogsteden HC, van den Bosch JM. Relationship between presentation of sarcoidosis and T lymphocyte profile: a study in bronchoalveolar lavage fluid. Chest 1993;104:795-800. (Pubitemid 23268950)
55. Trentin L, Migone N, Zambello R, di Celle PF, Aina F, Feruglio C, Bulian P, Masciarelli M, Agostini C, Cipriani A, et al. Mechanisms accounting for lymphocytic alveolitis in hypersensitivity pneumonitis. J Immunol 1990;145:2147-2154. (Pubitemid 20343378)
56. Depierre A, Dalphin JC, Pernet D, Dubiez A, Faucompre C, Breton JL. Epidemiological study of farmer's lung in five districts of the French Doubs province. Thorax 1988;43:429-435.
57. Kantrow SP, Meyer KC, Kidd P, Raghu G. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997;10:2716-2721. (Pubitemid 28052776)
58. Danila E, Norkūniene J, Jurgauskiene L, Malickaite R. Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis. Clin Respir J. 2009;3:214-221.
59. Barrera L, Mendoza F, Zuñiga J, Estrada A, Zamora AC, Melendro EI, Ramírez R, Pardo A, Selman M. Functional diversity of T-cell sub-populations in subacute and chronic hypersensitivity pneumonitis. Am J Respir Crit Care Med 2008;177:44-55.
60. Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Muñoz X. Bird fancier's lung: a series of 86 patients. Medicine (Baltimore) 2008;87:110-130. (Pubitemid 351419176)
61. Meyer KC, Soergel P. Bronchoalveolar lymphocyte phenotypes change in the normal aging human lung. Thorax 1999;54:697-700. (Pubitemid 29341406)